Department of Clinical Medicine

Du er her: » Stine Sofie Frank Lende » Publikationer » Persistent Severe Acute Respiratory Syndrome Coronavirus ...

Stine Sofie Frank Lende

Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Standard

Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution. / Monrad, Ida; Sahlertz, Signe Risgaard; Nielsen, Stine Sofie Frank et al.

I: Open Forum Infectious Diseases, Bind 8, Nr. 7, ofab295, 07.2021.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Harvard

Monrad, I, Sahlertz, SR, Nielsen, SSF, Pedersen, LØ, Petersen, MS, Kobel, CM, Tarpgaard, IH, Storgaard, M, Mortensen, KL, Schleimann, MH, Tolstrup, M & Vibholm, LK 2021, 'Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution', Open Forum Infectious Diseases, bind 8, nr. 7, ofab295. https://doi.org/10.1093/ofid/ofab295

APA

Monrad, I., Sahlertz, S. R., Nielsen, S. S. F., Pedersen, L. Ø., Petersen, M. S., Kobel, C. M., Tarpgaard, I. H., Storgaard, M., Mortensen, K. L., Schleimann, M. H., Tolstrup, M., & Vibholm, L. K. (2021). Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution. Open Forum Infectious Diseases, 8(7), [ofab295]. https://doi.org/10.1093/ofid/ofab295

CBE

Monrad I, Sahlertz SR, Nielsen SSF, Pedersen LØ, Petersen MS, Kobel CM, Tarpgaard IH, Storgaard M, Mortensen KL, Schleimann MH, et al. 2021. Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution. Open Forum Infectious Diseases. 8(7):Article ofab295. https://doi.org/10.1093/ofid/ofab295

MLA

Monrad, Ida et al. "Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution". Open Forum Infectious Diseases. 2021. 8(7). https://doi.org/10.1093/ofid/ofab295

Vancouver

Monrad I, Sahlertz SR, Nielsen SSF, Pedersen LØ, Petersen MS, Kobel CM et al. Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution. Open Forum Infectious Diseases. 2021 jul.;8(7):ofab295. doi: 10.1093/ofid/ofab295

Author

Monrad, Ida ; Sahlertz, Signe Risgaard ; Nielsen, Stine Sofie Frank et al. / Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution. I: Open Forum Infectious Diseases. 2021 ; Bind 8, Nr. 7.

Bibtex

@article{64ee7982b72f490296e31632d35fd4e7,
title = "Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution",
abstract = "We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment. ",
keywords = "CLL, persistent infection, SARS-CoV-2, viral evolution",
author = "Ida Monrad and Sahlertz, {Signe Risgaard} and Nielsen, {Stine Sofie Frank} and Pedersen, {Louise {\O}rnskov} and Petersen, {Mikkel Steen} and Kobel, {Carl Mathias} and Tarpgaard, {Irene Harder} and Merete Storgaard and Mortensen, {Klaus Leth} and Schleimann, {Mariane H.} and Martin Tolstrup and Vibholm, {Line K.}",
note = "Publisher Copyright: {\textcopyright} 2021 The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.",
year = "2021",
month = jul,
doi = "10.1093/ofid/ofab295",
language = "English",
volume = "8",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "7",

}

RIS

TY - JOUR

T1 - Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution

AU - Monrad, Ida

AU - Sahlertz, Signe Risgaard

AU - Nielsen, Stine Sofie Frank

AU - Pedersen, Louise Ørnskov

AU - Petersen, Mikkel Steen

AU - Kobel, Carl Mathias

AU - Tarpgaard, Irene Harder

AU - Storgaard, Merete

AU - Mortensen, Klaus Leth

AU - Schleimann, Mariane H.

AU - Tolstrup, Martin

AU - Vibholm, Line K.

N1 - Publisher Copyright: © 2021 The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

PY - 2021/7

Y1 - 2021/7

N2 - We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.

AB - We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.

KW - CLL

KW - persistent infection

KW - SARS-CoV-2

KW - viral evolution

UR - http://www.scopus.com/inward/record.url?scp=85112495039&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofab295

DO - 10.1093/ofid/ofab295

M3 - Journal article

C2 - 34258320

AN - SCOPUS:85112495039

VL - 8

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

SN - 2328-8957

IS - 7

M1 - ofab295

ER -